Oral phenobarbital loading: A safe and effective method of withdrawing patients with headache from butalbital compounds

Headache

Volumn 43, Issue 8, 2003, Pages 904-909

  Loder, Elizabeth ^a   Biondi, David ^b  

^a and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^b NONE

Author keywords

Barbiturate; Phenobarbital loading protocol; Rebound headache; Withdrawal

Indexed keywords

BARBITURIC ACID DERIVATIVE; PHENOBARBITAL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EVALUATION; HOSPITALIZATION; HUMAN; MIGRAINE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT;

ADMINISTRATION, ORAL; BARBITURATES; BEHAVIOR THERAPY; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; HEADACHE DISORDERS; HUMANS; HYPNOTICS AND SEDATIVES; INPATIENTS; PHENOBARBITAL; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0042237019     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2003.03171.x     Document Type: Article

References (10)

1. Silberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache. 2001;41:953-967.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1998;8(suppl 7):1-96.
3. Sands GH. A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. Headache. 1990;30:491-496.
4. Devenyi P, Rideout J, Schneiderman J. Abuse of a commonly prescribed analgesic preparation. Can Med Assoc J. 1985;113:294-296.
5. Martin PR, Bhushan CM, Kapur BM, Whiteside EA, Sellers EM. Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: a kinetic approach. Clin Pharmcol Ther. 1979;26:256-264.
6. Goodman A, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 6th ed. New York, NY: Macmillan Publishing Co, Inc; 1980: 457.
7. Sternbach RA. Behavioral therapies and headache. In: Dalessio DJ, ed., Wolff's Headache and Other Head Pain. 5th ed. New York, NY: Oxford University Press; 1987:392-393.
8. Silberstein S. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:754-762.
9. Raskin N. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995-997.
10. Sheftell FD, Rapoport AM, Coddon DR. Naratriptan in the prophylaxis of transformed migraine. Headache. 1999;39:506-510.